Company Filing History:
3 out of 869 
3 out of 5 
3 out of 5,076 
Years Active: 2021-2024
Title: Nimol Khim: Innovator in Malaria Research
Introduction
Nimol Khim is a prominent inventor based in Kandal, Cambodia. He has made significant contributions to the field of malaria research, particularly in the detection and treatment of drug-resistant strains of the disease. With a total of 3 patents to his name, Khim's work is vital in the ongoing battle against malaria.
Latest Patents
Khim's latest patents include innovative methods and reagents for detecting piperaquine-resistant Plasmodium falciparum malaria. One of his notable inventions is a method for genotyping that involves providing a sample and detecting the presence of an increased copy number of the genomic plasmepsin2-3 cluster. Additionally, he has developed a method for detecting infections in patients through blood samples, focusing on the presence of the same genomic cluster. His work also encompasses kits for genotyping and methods of treating infections. Another significant contribution is the identification of the K13-propeller polymorphism as a molecular marker for tracking artemisinin resistance in Plasmodium falciparum. This invention includes methods, compositions, and kits for detecting and genotyping the mutated K-13 propeller nucleic acid or protein in samples.
Career Highlights
Throughout his career, Nimol Khim has worked with esteemed organizations such as the Institut Pasteur and the Institut Pasteur du Cambodge. His research has been instrumental in advancing the understanding of malaria and its resistance to treatment.
Collaborations
Khim has collaborated with notable colleagues in the field, including Didier Menard and Benoit Witkowski. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Nimol Khim's contributions to malaria research through his patents and collaborations highlight his dedication to combating this global health issue. His innovative methods and findings are crucial in the fight against drug-resistant malaria, making him a key figure in the field.